The global biotechnology industry market size is projected to grow from USD 483.0 billion in 2024 to USD 546.0 billion by 2025, reflecting a strong compound annual growth rate (CAGR) of around 13.0%. Despite the recent economic uncertainty and post-Covid downturn, biotech companies have shown adaptability through 2024. The global biotech industry market size is estimated to grow from US$ 483.0 billion in 2024 to US$ 546.0 billion by 2025, with a growth rate of 13.0% driven by ongoing innovation, mergers and acquisitions (M&A), investments, and advanced therapies. Focusing on contributes to the sustainable growth of the market. The global biotechnology industry is poised to experience rapid growth and innovation, driven by the growing demand for personalized medicine, AI integration, and biologics. Industry will see widespread use of biologics, such as monoclonal antibodies and gene therapies, especially for complex diseases such as cancer, genetic disorders, and autoimmune conditions. Personalized medicine will take center stage, with treatments tailored to individual genetic profiles, improving efficacy and reducing side effects. Additionally, the use of AI and machine learning will significantly accelerate drug discovery, clinical trial design, and biomanufacturing processes, helping companies bring treatments to market faster and more cost-effectively. The biotechnology sector will also focus on sustainability, with a shift towards greener biomanufacturing practices. Innovations such as single-use bioprocessing, continuous biomanufacturing, and environmentally friendly production methods will reduce costs, improve product yields, and minimize the environmental impact of biological production.

The Global Biotech Industry Outlook to 2025 aims to provide insight into the expected performance of biotech sectors, covering the integration of AI in drug discovery and the development of innovative therapies. The report will assess the industry’s performance in 2024 compared to 2023 and highlight key developments and notable changes in the biotech landscape during 2024, with continued momentum expected through 2025. Market and Markets